BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9240109)

  • 1. An evaluation of educational outreach to general practitioners as part of a statewide cervical screening program.
    Stevens SA; Cockburn J; Hirst S; Jolley D
    Am J Public Health; 1997 Jul; 87(7):1177-81. PubMed ID: 9240109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pap smears in general practice: a secondary analysis of the Australian Morbidity and Treatment Survey 1990 to 1991.
    Reid SE; Simpson JM; Britt HC
    Aust N Z J Public Health; 1997 Jun; 21(3):257-64. PubMed ID: 9270150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The organization of cervical screening in general practice.
    Havelock C; Edwards R; Cuzick J; Chamberlain J
    J R Coll Gen Pract; 1988 May; 38(310):207-11. PubMed ID: 3210183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs and remuneration for cervical screening in general practice in the west of Scotland.
    Myles S; Wyke S; Ibbotson T; Macintyre S; McEwen J; Kelly M
    J Health Serv Res Policy; 1996 Oct; 1(4):217-23. PubMed ID: 10180874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adoption of liquid-based cervical cancer screening tests by family physicians and gynecologists.
    Rappaport KM; Forrest CB; Holtzman NA
    Health Serv Res; 2004 Aug; 39(4 Pt 1):927-47. PubMed ID: 15230935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing physicians' compliance with guidelines for Papanicolaou testing.
    Cohen MM; Roos NP; MacWilliam L; Wajda A
    Med Care; 1992 Jun; 30(6):514-28. PubMed ID: 1593917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
    Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
    Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact in general practice of the policies of the organised approach to preventing cancer of the cervix.
    Ward J; Donnelly N; Holt P
    Aust N Z J Public Health; 1998; 22(3 Suppl):336-41. PubMed ID: 9629819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk prevalence and screening for cancer by general practitioners.
    Heywood A; Sanson-Fisher R; Ring I; Mudge P
    Prev Med; 1994 Mar; 23(2):152-9. PubMed ID: 8047520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dealing with patients facing a history of sexual abuse: A cross-sectional survey among Dutch general practitioners.
    Birkhoff EM; Krouwel EM; Nicolai MP; de Boer BJ; Beck JJ; Putter H; Pelger RC; Elzevier HW
    Eur J Gen Pract; 2016 Jun; 22(2):126-33. PubMed ID: 26799644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change in Provider Beliefs Regarding Cervical Cancer Screening Intervals After an Educational Intervention.
    Benard VB; Greek A; Roland KB; Hawkins NA; Lin L; Saraiya M
    J Womens Health (Larchmt); 2016 May; 25(5):422-7. PubMed ID: 27096534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences among primary care physicians' adherence to 2009 ACOG guidelines for cervical cancer screening.
    Corbelli J; Borrero S; Bonnema R; McNamara M; Kraemer K; Rubio D; Karpov I; McNeil M
    J Womens Health (Larchmt); 2014 May; 23(5):397-403. PubMed ID: 24380500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rural physicians' perspectives on cervical and breast cancer screening: a gender-based analysis.
    Ahmad F; Stewart DE; Cameron JI; Hyman I
    J Womens Health Gend Based Med; 2001 Mar; 10(2):201-8. PubMed ID: 11268303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of an intervention to increase Pap test screening among Chinese women in Taiwan.
    Hou SI; Fernandez ME; Baumler E; Parcel GS
    J Community Health; 2002 Aug; 27(4):277-90. PubMed ID: 12190056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. General practice characteristics and use of Pap-smear.
    Hansen D; Ejlersen E; Olesen F
    Scand J Prim Health Care; 1991 Sep; 9(3):224. PubMed ID: 1754757
    [No Abstract]   [Full Text] [Related]  

  • 16. Access to cervical cancer screening: training internists so skill limitations are not a barrier to care.
    Charney P
    J Womens Health (Larchmt); 2006 Oct; 15(8):977-80. PubMed ID: 17087622
    [No Abstract]   [Full Text] [Related]  

  • 17. Have the most recent Pap smear guidelines affected GP practices?
    Wai D; Ferrier A; Collings S; Laverty C
    Aust Fam Physician; 1996 Jan; Suppl 1():S44-8. PubMed ID: 9479800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Costs of population cervical cancer screening program in Poland between 2007-2009].
    Spaczyński M; Karowicz-Bilinska A; Kedzia W; Molińska-Glura M; Seroczyński P; Januszek-Michalecka L; Rokita W; Nowak-Markwitz E
    Ginekol Pol; 2010 Oct; 81(10):750-6. PubMed ID: 21117303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Providers' practice, recommendations and beliefs about HPV vaccination and their adherence to guidelines about the use of HPV testing, 2007 to 2010.
    Berkowitz Z; Nair N; Saraiya M
    Prev Med; 2016 Jun; 87():128-131. PubMed ID: 26921654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time costs associated with cervical cancer screening.
    Shireman TI; Tsevat J; Goldie SJ
    Int J Technol Assess Health Care; 2001; 17(1):146-52. PubMed ID: 11329841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.